Company Email Format Management

Context Therapeutics

Biotechnology Research Philadelphia, Pennsylvania, United States 23 employees CNTX

Employees: 23
Contacts: 4
Emails: 4
Phones: 2

contexttherapeutics.com LinkedIn Crunchbase

Context Therapeutics Overview

Headquarters: Philadelphia, Pennsylvania, United States
Website: contexttherapeutics.com
Industry: Biotechnology Research
Employees: 23
Founded: 2015
Stock Symbol: CNTX
Funding: 100.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Oncology and Bispecific Antibody

About Context Therapeutics

Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company advancing T cell engaging ("TCE") bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics, including CTIM-76, a Claudin 6 x CD3 bispecific antibody, CT-95, a Mesothelin x CD3 bispecific antibody, and CT-202, a Nectin-4 x CD3 bispecific antibody. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.

Context Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Context Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Andy Pasternak	Biopharmaceutical Executive and Advisor	Greater Chicago Area, United States	Email Phone
Felix Kim	Molecular Pharmacologist and Cancer	Philadelphia, Pennsylvania, United States	Email
Alex Levit		Philadelphia, Pennsylvania, United States	Email
Jennifer Princivalle		Ambler, Pennsylvania, United States	Email Phone